MET and glioma: MET encodes the receptor for hepatocyte growth factor (HGF) and has great importance in the migration and invasiveness of glioma cells, such as in response to irradiation, inhibition of angiogenesis and hypoxia, and has a critical role in therapeutic resistance and recurrence of GBM [28,33,40].